Public offering of the Macro Group for Pharmaceuticals Company (Macro Capital) was oversubscribed 102 times, at the end of the period specified for registering buy and sell orders for it on Monday.
EGX indicated that the total quantities of purchase orders (initial quantity) registered in the private deals market amounted to 1.35 billion shares. As for the private offering of Macro Capital, it was oversubscribed by 1.79 times at a price of LE 4.85 per share.
The company seeks to offer up to 45.8 percent of the company’s shares, which represents 264.513 million shares, on the Egyptian Stock Exchange, 95 percent of which (251.287 million shares) are for private placement, and the remaining 5 percent through a public offering.
The company hopes that the total value of the public and private offerings will reach LE 1.3 billion. Hermes acts as the sole global coordinator for the offering, while Renaissance Capital co-manages the offering.
It began receiving requests to participate in the private and public offerings of “Macro Capital” since January 24, and by the end of the private offering on Wednesday, the public offering of the company’s shares is expected to end with the end of the trading session next Monday on the EGX, to start trading on the shares in the market during the same week.
If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.